Insulin Supply Chain

The WHO aims to enhance the global supply of insulin by pre-qualifying manufacturers, which could lead to lower prices for this vital medication. Seven manufacturers have shown interest, including one of the major players, while the rest are smaller companies eager to meet safety and effectiveness standards. The hope is that this initiative will mirror the success seen with HIV drugs in the early 2000s, potentially creating a ripple effect in the market.